| Prev Close | 48.67 |
| Open | 48.90 |
| Day Low/High | 48.80 / 49.50 |
| 52 Wk Low/High | 36.28 / 87.69 |
| Volume | 881.22K |
| Avg Volume | 1.82M |
Perrigo Co. Plc (PRGO)
49.24
0.57
1.17
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 135.87M |
| Market Cap | 6.54B |
| EPS | 0.90 |
| P/E Ratio | 50.68 |
| Div & Yield | 0.76 (1.60%) |
Latest News
McDonald's Takes Bite Out of Dow, but Nasdaq and S&P 500 at Records
The S&P 500 and Nasdaq both ended at records as the promise of tax reform from the White House fueled gains across major banks.
These Stocks Have Changed Direction
Finding bullish and bearish reversals in the market.
Midday Report: Macy's Sinks Kohl's; Wall Street Down for Day Three
Stocks fall for their third day in a row.
Closing Bell: U.S. Stocks Fall Over Session, Rise for May; Perrigo Bests S&P 500
Stocks significantly pared losses by the end of the session, though still ended slightly lower.
Here's a Case Where You Might Want to Get Naked
Having questioned the sanity of selling naked puts on individual securities in the previous post, here is an example of a strategy that a hedge fund, like myself, might utilize in selling naked puts and calls on a diversified index -- in this case t...
Beware of Selling Naked Puts (Part Deux)
"The strategy of shorting puts (and buying shares) has put more of my friends out of business than any other option strategy extant. And these are professional traders that got into such a soup! My experience is that most investors (amateur and pros...
The Good, the Bad and the Ugly (Late Afternoon Edition)
"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have I might be trading some of the earnings reports that will be released ...
Perrigo's Problems Continue
Perrigo continues to encounter more problems.
Perrigo Shares Fall After Disclosing DOJ Investigation
The search involves a Department of Justice Antitrust Division investigation in relation to drug pricing in the pharmaceutical industry
The Good, the Bad and the Ugly (Mid-Afternoon Edition)
"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as its vacation time at the Kass household and I want to take a swim with my fam...
Beware of Fastental as a Put Play
Over in Columnist Conversation, Paul Price endorses the idea of selling (naked) long-dated puts in Fastenal . I continue to feel that this is a poor idea, both in structure and in company target. Here's why: While the options market for FAST is nomi...
The Good, the Bad and the Ugly (2:45 p.m. Edition)
"You see, in this world there's two kinds of people, my friend: Those with loaded guns and those who dig. You dig." -- Blondie, "The Good, the Bad and the Ugly" As I will be shortly involved in a potentially lenghty meeting, there will be no "Takeaw...
Nobody's Perfect, but a Pox on Those Who Don't Admit It
"Mistakes are always forgivable, if one has the courage to admit them." --Bruce Lee This morning shares of Deutsche Bank are down by another 8% after the Sunday report of a large secondary offering of DB shares. I would continue to avoid these share...
Avoid Valeant, Perrigo, but Lap Up Soup
As I have written consistently in my Diary, there is a reasonable chance that the Valeant equity has little value. I obviously would not bottom fish in VRX. Nor would I pick at Perrigo . However, I have been adding to Campbell Soup and Hartford Fina...
Why Big Activist Is Targeting Tribune Media
Starboard Value recently disclosed a stake in the broadcaster, an investment suggesting a campaign pushing for stock buybacks, asset sales or an auction of the whole company could be next.
Memo to Paul Price on Fastenal
I covered my Fastenal short as posted. I think it is important to update all positions on a frequent basis. So Paul, what about your long Perrigo and short PRGO put position? Perhaps you should update!
Closing Bell: Volkswagen Secures Plea Deal; Trump Triggers Biotech Selloff
Wall Street secured gains again by late afternoon Wednesday in unpredictable trading following President-elect Donald Trump's first press conference since July.
Cramer: Reviewing S&P's Hit-and-Miss Parade
Even among the losers, buys are scarce.
Make Sure Your Portfolio Is Protected From Volatility
If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.
Watch Beaten-Down Drug Companies, Hospitals in 2017
There may be some diamonds-in-the-rough among pharmaceutical consolidators and hospital chains.
Allergan's a Bargain That Could Pop 20%
When it comes to Perrigo, many stubborn traders have been transformed into long-term investors.
Looking for Shorts (In All the Right Places)
In looking for shorts there is one important and underlying factor that governs my selection process: I try through rigorous analysis to identify sectors and companies with intermediate-term prospects that are deteriorating relative to consensus exp...
The Good, the Bad and the Ugly (2:30 PM Edition)
"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie in "The Good, the Bad and the Ugly." I did very little today, save adding to my bank/financial shorts. I moved back to Market Neutral. ...
Stressed Out: Valeant Shareholders Flee on McKesson Warning
The drugmaker's shares were hammered Friday on news that the industry is slashing prices.
Stressed Out: Free Cash Flow Is All That Counts Now for Valeant
With a $31 billion debt load, the drugmaker has to show it has the firepower needed to fend off creditors.
Stocks to Worry the Bullish Cabal
Here are some high-profile and widely-held stocks whose charts should concern the bullish cabal: Netflix Starbucks Disney Tesla Coca-Cola Prudential Ford Valeant Perrigo Dollar Tree Macy's Nike Note: These stocks represent a broad swath of secto...
Midday Report: American Airlines Falls on Weak August Traffic; U.S. Stocks Climb
Stocks climbed, though worries over how soon the Federal Reserve might hike interest rates kept markets wary.
